![](/img/cover-not-exists.png)
A39The acquired resistance to the combination of the anti-EGFR cetuximab and the MEK-inhibitor refametinib in KRAS mutated colorectal cancer cell lines depends on PI3K-signalling
Vitiello, P P, Viscardi, G, Martini, G, Cardone, C, Ciardiello, D, Belli, V, Matrone, N, Troiani, T, Napolitano, S, Sforza, V, De Falco, V, Giunta, E, Morgillo, F, Diadema, M R, Vitale, P, Zanaletti,Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx422.038
Date:
October, 2017
File:
PDF, 50 KB
english, 2017